{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:14:06Z","timestamp":1789848846863,"version":"4.0.1"},"reference-count":36,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"214","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2013,12,4]]},"abstract":"<jats:p>TCRB high-throughput sequencing can monitor response to therapy in a skin lymphoma patient population.<\/jats:p>","DOI":"10.1126\/scitranslmed.3007420","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T19:25:07Z","timestamp":1386185107000},"source":"Crossref","is-referenced-by-count":90,"title":["Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma"],"prefix":"10.1126","volume":"5","author":[{"given":"Wen-Kai","family":"Weng","sequence":"first","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Desmarais","sequence":"additional","affiliation":[{"name":"Adaptive Biotechnologies, Seattle, WA 98102, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hoppe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).","volume":"110","author":"Olsen E.","year":"2007","unstructured":"Olsen E., Vonderheid E., Pimpinelli N., Kim Y., Knobler R., Zackheim H., Duvic M., Estrach T., Lamberg S., Wood G., Dummer R., Ranki A., Burg G., Heald P., Pittelkow M., Bernengo M.-G., Sterry W., Laroche L., Trautinger F., Whittaker S.; ISCL\/EORTC, Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110, 1713\u20131722 (2007).","journal-title":"Blood"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.057"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08852.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.9.3369"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1309\/25E9Y7RRAY84HTAT"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06649.x","article-title":"T-cell receptor \u03b3 gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings.","volume":"153","author":"Ponti R.","year":"2005","unstructured":"Ponti R., Quaglino P., Novelli M., Fierro M. T., Comessatti A., Peroni A., Bonella L., Bernengo M. G., T-cell receptor \u03b3 gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings. Br. J. Dermatol. 153, 565\u2013573 (2005).","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2010.090123"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.2.609"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0604"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.624"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8301"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3241"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.201"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001442"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217604"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118357109"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003656"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3100"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08739.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.","volume":"29","author":"Olsen E. A.","year":"2011","unstructured":"Olsen E. A., Whittaker S., Kim Y. H., Duvic M., Prince H. M., Lessin S. R., Wood G. S., Willemze R., Demierre M. F., Pimpinelli N., Bernengo M. G., Ortiz-Romero P. L., Bagot M., Estrach T., Guitart J., Knobler R., Sanches J. A., Iwatsuki K., Sugaya M., Dummer R., Pittelkow M., Hoppe R., Parker S., Geskin L., Pinter-Brown L., Girardi M., Burg G., Ranki A., Vermeer M., Horwitz S., Heald P., Rosen S., Cerroni L., Dreno B., Vonderheid E. C.; International Society for Cutaneous LymphomasUnited States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer, Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J. Clin. Oncol. 29, 2598\u20132607 (2011).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.004"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.175"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.11.3021.3021"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402922"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404586"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.061259"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.52"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-489757"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2011.01.001"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-248146"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1309\/05GFG3LY3VYCDMEY"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3007420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:46:01Z","timestamp":1705427161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3007420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,4]]},"references-count":36,"journal-issue":{"issue":"214","published-print":{"date-parts":[[2013,12,4]]}},"alternative-id":["10.1126\/scitranslmed.3007420"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3007420","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,4]]}}}